DEFA14A: Integrated Wellness Sets Key Dates for Btab Merger & Extension Vote

Integrated Wellness Acquisition Corp. has scheduled shareholder meetings for December to vote on its proposed business combination with Btab Ecommerce Group and a deadline extension.

Summary

• Integrated Wellness Acquisition Corp. (the Company) filed definitive proxy statements for two extraordinary general meetings of shareholders.
• A Business Combination Meeting is scheduled for December 8, 2025, at 10:00 a.m. Eastern Time to approve the proposed business combination with Btab Ecommerce Group, Inc.
• An Extension Meeting is scheduled for December 12, 2025, at 10:00 a.m. Eastern Time to approve an amendment to the Company's charter, extending the business combination deadline from December 15, 2025, to March 16, 2026.
• Public shareholders are entitled to submit their public shares for redemption in connection with both meetings.
• As of November 3, 2025, the record date, the estimated per share redemption price was approximately $12.78.
• Shareholders wishing to redeem for the Business Combination and ensure redemption if the Extension is implemented must instruct the transfer agent to redeem for the Extension Meeting by its deadline.
• Redemption requests can be withdrawn prior to the shareholder vote or with the Company's consent thereafter.

Sentiment

Score: 5

Explanation: The filing is largely procedural, detailing steps for a business combination and a deadline extension. While the extension itself could be seen as a slight negative, the continued progress towards the merger and clear communication regarding shareholder options maintain a neutral sentiment.

Positives

• The company is moving forward with the necessary shareholder votes for the proposed business combination with Btab Ecommerce Group, Inc.
• Shareholders are provided with clear redemption options and instructions.

Negatives

• The need for an extension suggests potential challenges in closing the business combination by the original deadline.
• There is no assurance that the Company will hold the Extension Meeting and implement the Extension.
• Shareholders face complexity in managing redemption requests across two separate meetings.

Risks

• The proposed Business Combination may not be completed in a timely manner or at all, which may adversely affect the price of the Company's securities.
• The proposed Business Combination may not be completed by the Company's Business Combination deadline.
• Failure to satisfy the conditions to the consummation of the Business Combination.
• The occurrence of any event, change, or other circumstance that could give rise to the termination of the Business Combination Agreement.
• Failure to achieve the minimum amount of cash available following any redemptions by the Company's shareholders.
• Redemptions exceeding a maximum threshold or the failure to meet Nasdaq's initial listing standards in connection with the consummation of the contemplated Business Combination.
• The effect of the pendency of the Business Combination on Btab's business relationships, operating results, and business generally.
• Risks that the proposed Business Combination disrupts current plans and operations of Btab.
• The outcome of any legal proceedings that may be instituted against Btab or against the Company related to the Business Combination Agreement or the proposed Business Combination.

Future Outlook

The Company anticipates completing the business combination with Btab Ecommerce Group, Inc., subject to shareholder approval and satisfaction of closing conditions. It also seeks to extend its deadline to complete a business combination until March 16, 2026, to provide more time for the transaction. The filing highlights potential future financial condition and performance of Btab post-closing, expected financial impacts, and the pre-money valuation of Btab, all of which are subject to change and various risks.

Industry Context

This filing is typical for a Special Purpose Acquisition Company (SPAC) nearing its initial business combination deadline. SPACs often seek extensions to finalize mergers, especially when facing complex regulatory approvals, market volatility, or high redemption rates. The dual proxy statements for both the merger vote and an extension vote are common strategies to manage the timeline and shareholder redemptions.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: Will vote on the business combination and the extension. They have redemption rights at an estimated $12.78 per share. They face decisions regarding redemption timing and potential complexities if the Extension Meeting is not held.
• Btab Ecommerce Group, Inc.: The proposed business combination is pending, and its business relationships and operations could be disrupted by the pendency of the transaction.

Next Steps

• Hold the Business Combination Meeting on December 8, 2025, to vote on the proposed business combination with Btab Ecommerce Group, Inc.
• Hold the Extension Meeting on December 12, 2025, to vote on extending the business combination deadline to March 16, 2026.
• Shareholders to consider redemption options and submit requests by the Extension Meeting deadline if applicable.
• Company to continue working towards satisfying closing conditions for the Business Combination.

Key Dates

Keywords

SPAC, Business Combination, Btab Ecommerce Group, Proxy Statement, Shareholder Meeting, Redemption, Extension, Merger, Integrated Wellness Acquisition Corp, IWAC